Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial Frias JP, Deenadayalan S, Erichsen L, et al
Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic, T., Bilic, Z., Knezevic, M., Sever, M., Lojo, N., Kokot, A., Kolovrat, M., Drmic, D., Vukojevic, J., Kralj, T., Kasnik, K.,
Nwachukwu will check for any bone abnormalities and will correct them during surgery using a special tool to reshape the surface of the bone
doi:10.1016/j.otsr.2023.103737 Berzolla E, Sundaram V, Strauss E
Proper storage and careful handling help preserve peptide integrity and support consistent experimental outcomes
2.4% with placebo [8]